Presuming that KRAS gene mutations are frequently involved in human CRC development and particularly in the ‘serrated pathway’, this pathway may play an important role in feline intestinal carcinogenesis, as it does for human serrated adenocarcinomas [20,30,31,32]. This evidence concerns the gene KRAS and colorectal carcinoma.